QBFM
HALO icon

QS Batterymarch Financial Management’s Halozyme HALO Stock Holding History

QS Batterymarch Financial Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.15M Sell
126,159
-35,400
-22% -$337K 0.03% 503
2014
Q2 		$1.6M Sell
161,559
-18,300
-10% -$155K 0.04% 463
2014
Q1 		$2.29M Buy
+179,859
New +$2.67M 0.05% 470

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

QS Batterymarch Financial Management's HALO Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Halozyme (HALO) stake by 22% in Q3 2014, selling an estimated $337K and leaving 126,159 shares worth $1.15M. The position accounts for 0.03% of the portfolio, ranked #503.

QS Batterymarch Financial Management first reported a position in HALO in Q1 2014 and has held it in 3 quarters since. The position peaked at $2.29M in Q1 2014. 121 funds tracked by Wall St. Rank hold HALO as of Q3 2014.

  • QS Batterymarch Financial Management held 126,159 shares of Halozyme worth $1.15M as of Q3 2014.
  • QS Batterymarch Financial Management sold 35,400 Halozyme shares in Q3 2014, an estimated $337K.
  • Halozyme made up 0.03% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #503 holding.
  • QS Batterymarch Financial Management first reported a position in Halozyme in Q1 2014 and has held it in 3 quarters since.
  • QS Batterymarch Financial Management's Halozyme position peaked at $2.29M in Q1 2014.
  • 121 funds tracked by Wall St. Rank held Halozyme as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.